Daily Stock Analysis, NVCR, Novocure Ltd, priceseries

Novocure Ltd. Daily Stock Analysis
Stock Information
Open
69.55
Close
69.50
High
71.62
Low
67.27
Previous Close
69.46
Daily Price Gain
0.04
YTD High
84.84
YTD High Date
Feb 15, 2022
YTD Low
59.57
YTD Low Date
Jan 27, 2022
YTD Price Change
-10.60
YTD Gain
-13.23%
52 Week High
232.76
52 Week High Date
Jun 24, 2021
52 Week Low
59.57
52 Week Low Date
Jan 27, 2022
52 Week Price Change
-57.51
52 Week Gain
-45.28%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 1. 2017
13.15
Jul 17. 2017
18.33
31 Trading Days
39.41%
Link
LONG
Apr 10. 2018
20.85
May 15. 2018
28.29
25 Trading Days
35.67%
Link
LONG
Jul 2. 2018
32.00
Jul 26. 2018
35.43
17 Trading Days
10.73%
Link
LONG
Aug 21. 2018
36.55
Oct 4. 2018
51.24
31 Trading Days
40.20%
Link
LONG
Jan 4. 2019
33.62
Mar 4. 2019
52.37
39 Trading Days
55.76%
Link
LONG
Jun 27. 2019
60.85
Aug 23. 2019
92.68
40 Trading Days
52.31%
Link
LONG
Nov 12. 2019
80.81
Dec 2. 2019
88.69
13 Trading Days
9.75%
Link
LONG
Jan 14. 2020
82.41
Jan 24. 2020
87.86
7 Trading Days
6.61%
Link
LONG
Jul 17. 2020
63.14
Aug 11. 2020
74.82
17 Trading Days
18.49%
Link
LONG
Aug 17. 2020
76.60
Sep 4. 2020
80.92
14 Trading Days
5.64%
Link
LONG
Sep 9. 2020
85.45
Oct 21. 2020
128.88
30 Trading Days
50.82%
Link
LONG
Dec 1. 2020
126.97
Jan 4. 2021
165.34
22 Trading Days
30.22%
Link
LONG
May 24. 2021
185.24
Jul 1. 2021
206.69
27 Trading Days
11.58%
Link
LONG
Feb 4. 2022
71.24
Feb 18. 2022
76.19
10 Trading Days
6.96%
Link
Company Information
Stock Symbol
NVCR
Exchange
NasdaqGS
Company URL
http://www.novocure.com
Company Phone
44 (0)15 3475 6700
CEO
Asaf Danziger
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001645113
About

Novocure Ltd. operates as a commercial-stage oncology company, which offers devices for continuous home use by patients. It develops novottf-100A, a portable non-invasive investigational device for cancer treatment using tumor treating fields. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.

Description

Markets a wearable electric field device for treating glioblastoma brain cancer.